Next-generation proteomics in clinical research: trends and prospects

The seminar highlights Somalogic’s Next Generation Proteomics Platform, which enables the simultaneous detection of over 7,000 protein targets from liquid biopsy samples. This technology opens up new possibilities for biomarker discovery and validation, as well as for the development of proteomic signatures in clinical research. The presentation will provide an overview of this innovative approach and showcase examples of its applications in various areas of clinical research, particularly in immuno-oncology. Participants will gain a better understanding of the potential impact of next-generation proteomics on the advancement of clinical research and its future implications.

All seminars